Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00281_DB00382_nanopub.RAd0IQqQFfixkHP2b4dyR_tJBK0DAn5THMKjmkxnPRJj8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00281_DB00382 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00281_DB00382 label "DDI between Lidocaine and Tacrine - The metabolism of Tacrine, a CYP1A2 substrate, may be reduced by strong CYP1A2 inhibitors such as Lidocaine. Consider modifying therapy to avoid Tacrine toxicity. Monitor the efficacy and toxicity of Tacrine if Lidocaine is initiated, discontinued or if the dose is changed. [drugbank_resource:DB00281_DB00382]" assertion.
- drugbank_resource:DB00281_DB00382 identifier "drugbank_resource:DB00281_DB00382" assertion.
- drugbank_resource:DB00281_DB00382 title "DDI between Lidocaine and Tacrine - The metabolism of Tacrine, a CYP1A2 substrate, may be reduced by strong CYP1A2 inhibitors such as Lidocaine. Consider modifying therapy to avoid Tacrine toxicity. Monitor the efficacy and toxicity of Tacrine if Lidocaine is initiated, discontinued or if the dose is changed." assertion.
- drugbank:DB00281 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00281_DB00382 assertion.
- drugbank:DB00382 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00281_DB00382 assertion.